Home > Category > Signaling Pathways > PI3K/Akt/mTOR > Akt > Afuresertib-F HCl | GSK2110183-analog 1 HCl |

Afuresertib-F HCl | GSK2110183-analog 1 HCl |

ChemLeader 98+%

Catalog No：CL2088C CAS No.：2070009-64-0 MDLNo： Formula：C18H17Cl3F2N4OS MW：481.77

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Afuresertib-F HCl \| GSK2110183-analog 1 HCl \|
CAS	2070009-64-0
Formula	C18H17Cl3F2N4OS
MW	481.77
Storage condition	-20°C, protect from light, stored under nitrogen

Product details

GSK2110183 HCl, an analog ofAfuresertib, is a potent, orally bioavailable andATP-competitive Akt inhibitor with Ki of 0.08 nM, 2 nM, and 2.6 nM for Akt1, Akt2, and Akt3, respectively.

Related literature

Sorry, there is no relevant literature

CL2088B

Afuresertib-F free base | Afuresertib-F free base | GSK-2110183-analog 1

1047634-63-8 98+%

CL2088A

Afuresertib HCl | Afuresertib hydrochloride | GSK2110183 hydrochloride | LAE002 hydrochloride

1047645-82-8 98+%

CL2088

Afuresertib | GSK2110183 | LAE002

1047644-62-1 98+%

History

CL2088C

Afuresertib-F HCl | GSK2110183-analog 1 HCl |

2070009-64-0 98+%